U.S., Feb. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07414992) titled 'A Study of Radiation Therapy and Cemiplimab With or Without Fianlimab In People With Bladder Cancer' on Feb. 11.
Brief Summary: The researchers are doing this study to find out whether stereotactic body radiation therapy (SBRT) in combination with immunotherapy (cemiplimab with or without fianlimab) before cystectomy is an effective and safe treatment for people with muscle-invasive bladder cancer (MIBC).
Study Start Date: March, 2026
Study Type: INTERVENTIONAL
Condition:
Bladder Urothelial Carcinoma
Intervention:
RADIATION: Stereotactic body radiotherapy
Stereotactic body radiotherapy (SBRT) Tumor-directed SBRT will be deliv...